Moghimi S M, Patel H M
Department of Biochemistry, Charing Cross Hospital, Fulham Palace Road, W6 8RF, London, UK.
J Control Release. 2002 Jan 17;78(1-3):55-65. doi: 10.1016/s0168-3659(01)00481-3.
We have studied the blood clearance and reticuloendothelial organ distribution of intravenously injected neutral (egg phosphatidylcholine, egg PC/cholesterol, mol ratio 7:2), anionic (egg PC/cholesterol/dicetylphosphate, mol ratio 7:2:1), and cationic (egg PC/cholesterol/stearylamine, mol ratio 7:2:1) liposomes of approximately the same size distribution in mice 3 days after treatment with the synthetic oestrogen diethylstilbestrol (DES). Male mice administered DES intraperitoneally at a dose of 1 mg per mouse (body weight 22-25 g) manifested an increase in the vascular clearance rate of liposomes irrespective of the initial vesicle surface charge. The enhancement in the vascular clearance of liposomes in DES-treated animals was associated with a concomitant increase in liver weight as well as hepatic phagocytosis. However, DES treatment significantly enhanced the hepatic sequestration (on the basis of % of injected dose of liposomes per g of liver tissue) of positively charged liposomes when compared to both neutral and negatively charged vesicles of similar size distribution. This observation was also confirmed by the 'hepatic-blockade' experiments where blockade was induced by prior intravenous injection of liposomes of the same size distribution and charge to that of test vesicles. The in vitro cell suspension studies suggested that the enhanced liposome uptake (irrespective of the initial vesicle surface charge) by Kupffer cells of DES-treated mice was independent of changes in the blood opsonization processes. Furthermore, in vitro studies also showed the operation of multiple mechanisms and involvement of different populations of liver macrophages (resident and recruited cells) in liposome recognition following DES treatment. For example, in DES-treated animals, the newly recruited liver macrophages were found to play a major role in the clearance of stearylamine incorporated liposomes via complement receptors (Mac-1). The resident Kupffer cells seem to recognize cationic vesicles via other receptors as the expression of Mac-1 is virtually absent in these cells. On the other hand, complement receptors seem to play a minor role in the uptake of anionic DCP vesicles by hepatic macrophages of DES-treated mice. DES appears to offer a new approach in dissecting the mechanisms of liposome-macrophage interaction.
我们研究了在给小鼠注射合成雌激素己烯雌酚(DES)3天后,静脉注射的大小分布大致相同的中性(鸡蛋磷脂酰胆碱,鸡蛋PC/胆固醇,摩尔比7:2)、阴离子(鸡蛋PC/胆固醇/二鲸蜡基磷酸酯,摩尔比7:2:1)和阳离子(鸡蛋PC/胆固醇/硬脂胺,摩尔比7:2:1)脂质体的血液清除率和网状内皮器官分布。以每只小鼠(体重22 - 25 g)1 mg的剂量腹腔注射DES的雄性小鼠,无论初始囊泡表面电荷如何,脂质体的血管清除率均有所增加。DES处理动物中脂质体血管清除率的提高与肝脏重量以及肝脏吞噬作用的同时增加有关。然而,与大小分布相似的中性和带负电的囊泡相比,DES处理显著增强了带正电脂质体在肝脏中的滞留(基于每克肝组织中脂质体注射剂量的百分比)。“肝脏阻断”实验也证实了这一观察结果,在该实验中,通过预先静脉注射与测试囊泡大小分布和电荷相同的脂质体来诱导阻断。体外细胞悬浮研究表明,DES处理小鼠的库普弗细胞对脂质体摄取的增强(无论初始囊泡表面电荷如何)与血液调理过程中的变化无关。此外,体外研究还表明,DES处理后,多种机制发挥作用,不同群体的肝脏巨噬细胞(驻留细胞和募集细胞)参与脂质体识别。例如,在DES处理的动物中,发现新募集的肝脏巨噬细胞通过补体受体(Mac-1)在清除掺入硬脂胺的脂质体中起主要作用。驻留的库普弗细胞似乎通过其他受体识别阳离子囊泡,因为这些细胞中几乎不存在Mac-1的表达。另一方面,补体受体在DES处理小鼠的肝脏巨噬细胞摄取阴离子DCP囊泡中似乎起次要作用。DES似乎为剖析脂质体 - 巨噬细胞相互作用的机制提供了一种新方法。